US7195763B2ExpiredUtilityA1

Surface proteins from gram-positive bacteria having highly conserved motifs and antibodies that recognize them

85
Assignee: TEXAS A & M UNIVERISITY SYSTEMPriority: May 8, 2001Filed: Aug 5, 2004Granted: Mar 27, 2007
Est. expiryMay 8, 2021(expired)· nominal 20-yr term from priority
A61K 39/00C07K 14/31C07K 14/3156Y10S930/29A61K 2039/505C07K 14/315C07K 16/1267
85
PatentIndex Score
18
Cited by
6
References
5
Claims

Abstract

Isolated peptide sequences and proteins containing these sequences are provided which are useful in the prevention and treatment of infection caused by Gram-positive bacteria. The peptide sequences have been shown to be highly conserved motifs in the surface proteins of Gram-positive bacteria, and these consensus sequences include amino acid sequences such as LPXTG (SEQ ID NO:13), ALKTGKIDIIISGMTSTPERKK (SEQ ID NO:14), VEGAVVEKPVAEAYLKQN (SEQ ID NO:15), and EYAGVDIDLAKKIAK (SEQ ID NO:16). By virtue of the highly conserved regions, the sequences and the proteins including these sequences can be utilized to generate antibodies which can recognize these highly conserved motifs and the proteins containing them and thus be useful in the treatment or prevention of a wide range of infections caused by Gram-positive bacteria.

Claims

exact text as granted — not AI-modified
1. An isolated antibody capable of binding an amino acid sequence selected from the group consisting of ALKTGKIDIIISGMTSTPERKK (SEQ ID NO: 14), VEGAVVEKPVAEAYLKQN (SEQ ID NO: 15), and EYAGVDIDLAKKIAK (SEQ ID NO: 16). 
     
     
       2. The antibody according to  claim 1 , wherein the antibody is a monoclonal antibody. 
     
     
       3. The antibody according to  claim 1 , wherein the antibody is a polyclonal antibody. 
     
     
       4. A pharmaceutical composition comprising the isolated antibody according to  claim 1  and a pharmaceutically acceptable vehicle, carrier or excipient. 
     
     
       5. Isolated antisera containing an antibody according to  claim 1 .

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.